Asunercept (APG101, CAN008) is a soluble CD95-Fc fusion protein targeting CD95L. Asunercept disrupts CD95/CD95L signaling by selectively binding to CD95L. Asunercept can be used in the research of glioblastoma multiforme (GBM), myelodysplastic syndrome (MDS), and graft-versus-host disease (GvHD).
CAS Number:
[1450882-18-4]
Target:
TNF Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
